NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602 | -96.5% | 188 | -94.0% | 0.00% | -100.0% |
| Q1 2022 | $16,995 | +107.2% | 3,153 | +419.4% | 0.01% | +100.0% |
| Q4 2021 | $8,201 | -18.6% | 607 | +8.2% | 0.00% | -25.0% |
| Q3 2021 | $10,076 | +4.7% | 561 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $9,627 | -14.2% | 561 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $11,220 | +17.6% | 561 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $9,537 | +2.5% | 561 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $9,307 | -28.4% | 561 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $12,993 | +29.7% | 561 | 0.0% | 0.01% | +16.7% |
| Q1 2020 | $10,014 | – | 561 | – | 0.01% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2019 | $427 | -57.6% | 12 | -60.0% | 0.00% | -100.0% |
| Q1 2019 | $1,008 | +2.2% | 30 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $986 | -88.8% | 30 | -79.2% | 0.00% | -83.3% |
| Q3 2018 | $8,778 | -56.5% | 144 | -65.1% | 0.01% | -57.1% |
| Q2 2018 | $20,167 | -21.3% | 413 | +71.4% | 0.01% | -22.2% |
| Q1 2018 | $25,609 | -81.5% | 241 | -89.6% | 0.02% | -82.2% |
| Q4 2017 | $138,312 | +204.4% | 2,316 | +22.3% | 0.10% | +188.6% |
| Q3 2017 | $45,432 | +10.6% | 1,893 | -9.9% | 0.04% | +6.1% |
| Q2 2017 | $41,094 | -15.3% | 2,102 | +1.6% | 0.03% | -19.5% |
| Q1 2017 | $48,536 | +153.7% | 2,068 | +32.6% | 0.04% | +141.2% |
| Q4 2016 | $19,129 | -28.6% | 1,559 | 0.0% | 0.02% | -29.2% |
| Q3 2016 | $26,784 | +20.7% | 1,559 | 0.0% | 0.02% | +14.3% |
| Q2 2016 | $22,185 | +3.5% | 1,559 | 0.0% | 0.02% | +5.0% |
| Q1 2016 | $21,436 | – | 1,559 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |